Fatal pulmonary tumour thrombotic microangiopathy in patient with ovarian adenocarcinoma: review and a case report

[1]  K. Hirata,et al.  Imatinib Dramatically Improved Pulmonary Hypertension Caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) Associated with Metastatic Breast Cancer. , 2020, International Heart Journal.

[2]  Y. Ajioka,et al.  Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature , 2019, World Journal of Gastroenterology.

[3]  C. Febres-Aldana,et al.  Recurrent metastatic breast cancer manifesting as pulmonary tumor thrombotic microangiopathy with interstitial pulmonary fibrosis and infarcts: A clinicopathological correlation , 2019, Respiratory medicine case reports.

[4]  J. Cho,et al.  Fatal progressive right heart failure in a pancreatic cancer patient , 2019, Yeungnam University Journal of Medicine.

[5]  R. Saggar,et al.  Pulmonary tumor thrombotic microangiopathy: a systematic review , 2019, Pulmonary circulation.

[6]  Publisher's Note , 2018, Anaesthesia.

[7]  R. Suh,et al.  Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series , 2017, Pulmonary circulation.

[8]  S. Ohno,et al.  A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy , 2017, Case Reports in Oncology.

[9]  R. Robinson,et al.  Acute cor pulmonale due to pulmonary tumour thrombotic microangiopathy from renal cell carcinoma , 2017, BMJ Case Reports.

[10]  B. Oronsky,et al.  Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? , 2016, Case Reports in Oncology.

[11]  K. Dimopoulos,et al.  Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? , 2015, European Respiratory Journal.

[12]  A. Ho,et al.  The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature , 2015, BMC Cancer.

[13]  T. Imamura,et al.  Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy. , 2015, International heart journal.

[14]  H. Matsubara,et al.  A case report of pulmonary tumor thrombotic microangiopathy (PTTM) caused by esophageal squamous cell carcinoma , 2013, Esophagus.

[15]  Håkon Johansen,et al.  Former cancer patient in her 40s with chest pain and increasing dyspnoea. , 2012, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[16]  Y. Tokuda,et al.  Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature. , 2010, Pathology, research and practice.

[17]  A. Nicholson,et al.  Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. , 2008, International journal of cardiology.

[18]  Y. Ohkura,et al.  Pulmonary tumor thrombotic microangiopathy caused by a gastric carcinoma expressing vascular endothelial growth factor and tissue factor , 2005, Pathology international.

[19]  H. Otto,et al.  Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension , 1990, Cancer.

[20]  I. Yamadori,et al.  Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. , 2013, Internal medicine.

[21]  H. Shigematsu,et al.  Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy. , 2012, Internal medicine.